Data as of Aug 16, 2026 · Based on 3,131,739 AI responses across 10,525 prompts · See how Parse measures this
Ozempicozempic.comOzempic® is a GLP-1 receptor agonist containing semaglutide, used alongside diet and exercise to improve blood sugar in adults with type 2 diabetes. It is also FDA-approved to lower the risk of major cardiovascular events in adults with type 2 diabetes and known heart disease, and to reduce the risk of worsening kidney disease, kidney failure, and cardiovascular death in those with chronic kidney disease.
Sources
healthline.com shapes more of what AI says about Ozempic than any other source, at 23% of its citations.
nypost.com · goodrx.com · thetimes.co.uk · academic.oup.com
The market map
Healthy Snacks and Functional Supplements →